Milestone Pharmaceuticals Inc. — Form 8-K
Filed October 28, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 78/100
What the filing says
On October 23, 2026, Milestone Pharmaceuticals received a notice from its listing exchange regarding failure to satisfy continued listing standards. The company trades under ticker symbol MIST (CIK 0001408443). No specific cure period, financial metrics, or remediation details are disclosed in this 8-K filing.
Why this rating
Delisting notice is a major corporate event threatening exchange listing status and market access, highly material for a $98.9M market-cap company regardless of underlying cause or outcome.
Extracted items
Price action (we called it negative)
before filing · preread $0.76 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.